Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1Blood Coagulation Disorders 1Afibrinogenemia 1

Interventions

Specimen Handling 327Magnetic Resonance Spectroscopy 278pembrolizumab 268Carboplatin 190Cyclophosphamide 187Biopsy 183Cisplatin 163Gemcitabine 138Paclitaxel 137Bevacizumab 124fludarabine 122Nivolumab 119Radiotherapy 116Oxaliplatin 94venetoclax 92Docetaxel 90Fluorouracil 89Capecitabine 89Dexamethasone 86Drug Therapy 77Pemetrexed 75Rituximab 74Leucovorin 72durvalumab 71Blood Specimen Collection 70Radiosurgery 69Standard of Care 68atezolizumab 67Doxorubicin 66Radiation 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × cryoprecipitate coagulum × 90 days × Clear all
NCT06617897 2026-03-11

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

CSL Behring

Phase 3 Recruiting
90 enrolled

Afibrinogenemia, Blood Coagulation Disorders, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡